Back to Rare Disease
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT03680365

NCT03680365
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You are either a person with Duchenne Muscular Dystrophy (DMD) who is 11 years old or older, OR a parent or legal guardian of a child under 18 who has DMD
  • You have an official written diagnosis confirming you or your child has DMD
  • You currently live in the United States
  • You are able to read, write, and communicate in English
  • You are able to give your own consent to take part in the study
  • You are willing to take part in a 45-minute phone interview
  • You are able to view or receive a document before or during the interview, either online, by text message, by fax, or by regular mail

Who may not be able to join:

  • Anyone who does not meet all of the requirements listed above

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Jett Foundation, Inc.
Registry
clinicaltrials_gov
Start date
20 September 2018
Est. completion
15 March 2019

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Patient/Parent Interview Assessing Treatment Needs

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov